Ravindra pal Singh

Dr. Ravindra pal Singh


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2024 in Molecular Diversity
Verified
Journal Article
Closed access
PDF file
SKSumaiya Kifayat
Sumaiya Kifayat
HAHaider Thaer Abdulhameed Almuqdadi
Haider Thaer Abdulhameed Almuqdadi
RSRavindra pal Singh
Ravindra pal Singh
MSMithilesh Singh
Mithilesh Singh
MAMOHAMMAD ABID
MOHAMMAD ABID
Bharat Kumar Reddy SanapalliBharat Kumar Reddy Sanapalli
Bharat Kumar Reddy Sanapalli

1 July 2024 in Annals of Phytomedicine An International Journal
Verified
Journal Article
Closed access
SPSadia Parveen
Sadia Parveen
RSRavindra pal Singh
Ravindra pal Singh
GRGulshan Rathore
Gulshan Rathore


9 June 2026 in Journal of Biomaterials Science, Polymer Edition
Verified
Journal Article
Closed access
AKAvnish Kumar
Avnish Kumar
GRGulshan Rathore
Gulshan Rathore
AVAnurag Verma
Anurag Verma
RSRavindra pal Singh
Ravindra pal Singh
1. Drug administration via the buccal route is a potential bypass for conventional oral dosage forms, particularly for drugs prone to high first-pass hepatic metabolism or the breakdown of gastroin...


13 May 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
ACArsh Chanana
Arsh Chanana
YKYUKTA RAJESH KULKARNI Rajesh YUKTA RAJESH KULKARNI
YUKTA RAJESH KULKARNI Rajesh YUKTA RAJESH KULKARNI
RSRavindra pal Singh
Ravindra pal Singh
A significant clinical care challenge is infection management in wounds, particularly in light of the growing incidence of bacteria resistant to antibiotics. Innovative wound-healing materials have prompted the incorporation of cutting-edge technology, such hydrogels coated with silver nanoparticles (AgNPs), which provide dual-action antibacterial tactics. The broad-spectrum antibacterial qualities of silver nanoparticles cause structural damage and growth inhibition by interacting with bacterial cell membranes and releasing silver ions. By targeting the development of bacterial cell walls, cell wall synthesis inhibitors further reduce bacterial growth and improve the overall effectiveness of treatment. Additional advantages of incorporating these agents into the hydrogel matrix include moisture retention, controlled medication release, and the capacity to adapt to wound surfaces, all of which support the development of a favourable environment for tissue regeneration. Additionally, the hydrogels may release antibiotics and silver nanoparticles locally and continuously, promoting wound healing and avoiding infections. The mechanisms of cell wall synthesis inhibitors and silver nanoparticles in wound infection prevention are examined in this study, emphasizing how they may work together to promote wound healing. By tackling the problems of infection and encouraging quicker, more effective healing results, such sophisticated systems hold great potential for the treatment of contemporary wounds.